TABLE 1.
Patient Characteristics of Angiographic Group
| Parameter | Overall | Significant CAD | No significant CAD | P |
|---|---|---|---|---|
| n | 341 | 206 (60.4) | 135 (39.6) | |
| Age (y) | 71.3 ± 12.2 | 73.5 ± 11.5 | 68.0 ± 12.6 | <0.001 |
| Male sex | 229 (67.2) | 142 (68.9) | 87 (64.4) | 0.411 |
| Body mass index (kg/m2) | 28.5 ± 6.7 | 28.0 ± 6.1 | 29.2 ± 7.4 | 0.127 |
| Hypertension | 260 (76.2) | 161 (78.2) | 99 (73.3) | 0.362 |
| Dyslipidemia | 214 (62.8) | 130 (63.1) | 84 (62.2) | 0.909 |
| Diabetes | 122 (35.8) | 74 (35.9) | 48 (35.6) | 0.999 |
| Family history of CAD | 50 (14.7) | 29 (14.1) | 21 (15.6) | 0.755 |
| Smoking | 31 (9.1) | 14 (6.8) | 17 (12.6) | 0.083 |
| PVD | 38 (11.1) | 29 (14.1) | 9 (6.7) | 0.035 |
| History of CAD | 0 (0) | 0 (0) | 0 (0) | |
| Stress agent | ||||
| Regadenoson | 324 (95.0) | 196 (95.1) | 128 (94.8) | 0.576 |
| Adenosine | 16 (4.7) | 10 (4.9) | 6 (4.4) | |
| Dipyridamole | 1 (0.3) | 1 (0.7) | 0 (0) |
PVD = peripheral vascular disease.
Categoric values are expressed as n with percentage in parentheses; continuous values are expressed as mean ± SD.